Yuval Cohen's Stock Transactions in Corbus Pharmaceuticals

Yuval Cohen, the Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc., engaged in several stock transactions between October 24 and October 27, 2025. Cohen acquired 18,660 shares of common stock at $4.26 per share and subsequently sold the same number of shares at $17.01 per share on October 24. On October 27, he acquired 8,973 shares at $4.26 per share and sold them at $17.14 per share. These transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. Additionally, Cohen exercised stock options, disposing of 18,660 and 8,973 options on October 24 and October 27, respectively, with an exercise price of $4.26 per share. The transactions reflect Cohen's ongoing management of his equity holdings in the company.